vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and ORMAT TECHNOLOGIES, INC. (ORA). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $276.0M, roughly 1.8× ORMAT TECHNOLOGIES, INC.). ORMAT TECHNOLOGIES, INC. runs the higher net margin — 11.4% vs -10.1%, a 21.5% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 19.6%). ORMAT TECHNOLOGIES, INC. produced more free cash flow last quarter ($-40.0M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 11.0%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Ormat Technologies, Inc. is an international company based in Reno, Nevada, United States. Ormat supplies alternative and renewable geothermal energy technology. The company has built over 190 power plants and installed over 3,200 MW of output. As of January 2021 it owns and operates 933 MW of geothermal and recovered energy based power plants. Ormat has supplied over 1000 turbochargers worldwide, in North America, South America, Europe, Australia, and Asia. The company's products also includ...

CLOV vs ORA — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.8× larger
CLOV
$487.7M
$276.0M
ORA
Growing faster (revenue YoY)
CLOV
CLOV
+25.1% gap
CLOV
44.7%
19.6%
ORA
Higher net margin
ORA
ORA
21.5% more per $
ORA
11.4%
-10.1%
CLOV
More free cash flow
ORA
ORA
$28.9M more FCF
ORA
$-40.0M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
11.0%
ORA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
ORA
ORA
Revenue
$487.7M
$276.0M
Net Profit
$-49.3M
$31.4M
Gross Margin
28.6%
Operating Margin
-10.1%
15.4%
Net Margin
-10.1%
11.4%
Revenue YoY
44.7%
19.6%
Net Profit YoY
-123.2%
-23.2%
EPS (diluted)
$0.51

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ORA
ORA
Q4 25
$487.7M
$276.0M
Q3 25
$496.6M
$249.7M
Q2 25
$477.6M
$234.0M
Q1 25
$462.3M
$229.8M
Q4 24
$337.0M
$230.7M
Q3 24
$331.0M
$211.8M
Q2 24
$356.3M
$213.0M
Q1 24
$346.9M
$224.2M
Net Profit
CLOV
CLOV
ORA
ORA
Q4 25
$-49.3M
$31.4M
Q3 25
$-24.4M
$24.1M
Q2 25
$-10.6M
$28.0M
Q1 25
$-1.3M
$40.4M
Q4 24
$-22.1M
$40.8M
Q3 24
$-9.2M
$22.1M
Q2 24
$7.4M
$22.2M
Q1 24
$-19.2M
$38.6M
Gross Margin
CLOV
CLOV
ORA
ORA
Q4 25
28.6%
Q3 25
25.6%
Q2 25
24.3%
Q1 25
31.7%
Q4 24
31.9%
Q3 24
24.5%
27.8%
Q2 24
30.3%
28.8%
Q1 24
23.6%
35.2%
Operating Margin
CLOV
CLOV
ORA
ORA
Q4 25
-10.1%
15.4%
Q3 25
-4.9%
16.2%
Q2 25
-2.2%
15.1%
Q1 25
-0.3%
22.2%
Q4 24
-6.4%
21.3%
Q3 24
-2.7%
16.8%
Q2 24
2.0%
16.5%
Q1 24
-6.5%
23.5%
Net Margin
CLOV
CLOV
ORA
ORA
Q4 25
-10.1%
11.4%
Q3 25
-4.9%
9.7%
Q2 25
-2.2%
12.0%
Q1 25
-0.3%
17.6%
Q4 24
-6.6%
17.7%
Q3 24
-2.8%
10.4%
Q2 24
2.1%
10.4%
Q1 24
-5.5%
17.2%
EPS (diluted)
CLOV
CLOV
ORA
ORA
Q4 25
$0.51
Q3 25
$0.39
Q2 25
$0.46
Q1 25
$0.66
Q4 24
$0.67
Q3 24
$0.36
Q2 24
$0.37
Q1 24
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ORA
ORA
Cash + ST InvestmentsLiquidity on hand
$78.3M
$147.4M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$308.7M
$2.5B
Total Assets
$541.0M
$6.2B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ORA
ORA
Q4 25
$78.3M
$147.4M
Q3 25
$79.6M
Q2 25
$88.5M
Q1 25
$112.7M
Q4 24
$194.5M
$94.4M
Q3 24
$288.0M
$88.1M
Q2 24
$254.8M
$66.3M
Q1 24
$208.3M
$201.5M
Total Debt
CLOV
CLOV
ORA
ORA
Q4 25
$2.7B
Q3 25
Q2 25
Q1 25
Q4 24
$2.3B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
ORA
ORA
Q4 25
$308.7M
$2.5B
Q3 25
$340.9M
$2.5B
Q2 25
$344.2M
$2.5B
Q1 25
$336.1M
$2.5B
Q4 24
$341.1M
$2.4B
Q3 24
$342.2M
$2.4B
Q2 24
$324.9M
$2.4B
Q1 24
$292.5M
$2.4B
Total Assets
CLOV
CLOV
ORA
ORA
Q4 25
$541.0M
$6.2B
Q3 25
$559.7M
$6.1B
Q2 25
$575.0M
$6.0B
Q1 25
$583.7M
$5.8B
Q4 24
$580.7M
$5.7B
Q3 24
$653.0M
$5.6B
Q2 24
$674.2M
$5.5B
Q1 24
$671.8M
$5.5B
Debt / Equity
CLOV
CLOV
ORA
ORA
Q4 25
1.05×
Q3 25
Q2 25
Q1 25
Q4 24
0.97×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ORA
ORA
Operating Cash FlowLast quarter
$-66.9M
$105.0M
Free Cash FlowOCF − Capex
$-69.0M
$-40.0M
FCF MarginFCF / Revenue
-14.1%
-14.5%
Capex IntensityCapex / Revenue
0.4%
52.6%
Cash ConversionOCF / Net Profit
3.35×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$-284.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ORA
ORA
Q4 25
$-66.9M
$105.0M
Q3 25
$12.1M
$45.2M
Q2 25
$5.4M
$96.9M
Q1 25
$-16.3M
$88.0M
Q4 24
$34.8M
$158.6M
Q3 24
$50.0M
$106.4M
Q2 24
$44.8M
$30.7M
Q1 24
$25.9M
$115.2M
Free Cash Flow
CLOV
CLOV
ORA
ORA
Q4 25
$-69.0M
$-40.0M
Q3 25
$11.4M
$-102.1M
Q2 25
$4.8M
$-37.9M
Q1 25
$-16.5M
$-104.6M
Q4 24
$33.3M
$30.9M
Q3 24
$49.6M
$-3.3M
Q2 24
$44.4M
$-116.1M
Q1 24
$25.5M
$11.8M
FCF Margin
CLOV
CLOV
ORA
ORA
Q4 25
-14.1%
-14.5%
Q3 25
2.3%
-40.9%
Q2 25
1.0%
-16.2%
Q1 25
-3.6%
-45.5%
Q4 24
9.9%
13.4%
Q3 24
15.0%
-1.6%
Q2 24
12.5%
-54.5%
Q1 24
7.3%
5.3%
Capex Intensity
CLOV
CLOV
ORA
ORA
Q4 25
0.4%
52.6%
Q3 25
0.1%
59.0%
Q2 25
0.1%
57.6%
Q1 25
0.0%
83.8%
Q4 24
0.5%
55.4%
Q3 24
0.1%
51.8%
Q2 24
0.1%
69.0%
Q1 24
0.1%
46.1%
Cash Conversion
CLOV
CLOV
ORA
ORA
Q4 25
3.35×
Q3 25
1.87×
Q2 25
3.45×
Q1 25
2.18×
Q4 24
3.89×
Q3 24
4.82×
Q2 24
6.04×
1.38×
Q1 24
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

ORA
ORA

Electricity$186.6M68%
Products$63.1M23%
Energy Storage Segment$26.3M10%
Product Segment$1.2M0%

Related Comparisons